SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)

Francisco Ayala de la Peña1, Silvia Antolín Novoa2, Joaquín Gavilá Gregori3

  • 1Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Hospital Oncológico y de Terapias Avanzadas, Calle Maiquez 7, 28007, Madrid, Spain. frayala@ucm.es.

Insights

This guideline updates early-stage breast cancer treatment strategies in Spain, incorporating new diagnostic tools and therapies like immunotherapy. It aims to improve patient outcomes while managing treatment toxicity effectively.

Area of Science:

  • Oncology
  • Clinical Practice Guidelines

Background:

  • Breast cancer is the leading cause of cancer among women in Spain, with a rising incidence.
  • Screening programs detect most cases at early, curable stages.
  • Advances in diagnostics and therapies are improving the efficacy and safety of breast cancer treatment.

Purpose of the Study:

  • To provide an updated clinical practice guideline for early-stage breast cancer management.
  • To integrate recent advancements in diagnostic tools and therapeutic strategies.
  • To offer expert consensus for optimal patient care in Spain.

Main Methods:

  • Systematic review of relevant scientific studies.
  • Consensus development among experts from GEICAM, SOLTI, and SEOM.
  • Focus on early-stage breast cancer (updated for 2025).

Main Results:

  • Identification of improved locoregional and systemic therapies.
  • Evaluation of novel strategies including immunotherapy, targeted drugs, and antibody-drug conjugates.
  • Assessment of enhanced toxicity-benefit balance in treatment.

Conclusions:

  • The guideline incorporates new diagnostic and therapeutic advancements for early-stage breast cancer.
  • It emphasizes optimizing treatment to improve outcomes and minimize toxicity.
  • It serves as a crucial resource for oncologists in Spain.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...